NBTX
Price
$4.53
Change
-$0.20 (-4.23%)
Updated
Jun 27 closing price
Capitalization
220.86M
66 days until earnings call
PBYI
Price
$3.33
Change
+$0.02 (+0.60%)
Updated
Jun 27 closing price
Capitalization
165.29M
31 days until earnings call
Interact to see
Advertisement

NBTX vs PBYI

Header iconNBTX vs PBYI Comparison
Open Charts NBTX vs PBYIBanner chart's image
Nanobiotix SA
Price$4.53
Change-$0.20 (-4.23%)
Volume$4.35K
Capitalization220.86M
Puma Biotechnology
Price$3.33
Change+$0.02 (+0.60%)
Volume$699.74K
Capitalization165.29M
NBTX vs PBYI Comparison Chart in %
Loading...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NBTX vs. PBYI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBTX is a Buy and PBYI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NBTX: $4.53 vs. PBYI: $3.33)
Brand notoriety: NBTX and PBYI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NBTX: 46% vs. PBYI: 193%
Market capitalization -- NBTX: $220.86M vs. PBYI: $165.29M
NBTX [@Biotechnology] is valued at $220.86M. PBYI’s [@Biotechnology] market capitalization is $165.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBTX’s FA Score shows that 0 FA rating(s) are green whilePBYI’s FA Score has 1 green FA rating(s).

  • NBTX’s FA Score: 0 green, 5 red.
  • PBYI’s FA Score: 1 green, 4 red.
According to our system of comparison, PBYI is a better buy in the long-term than NBTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBTX’s TA Score shows that 4 TA indicator(s) are bullish while PBYI’s TA Score has 3 bullish TA indicator(s).

  • NBTX’s TA Score: 4 bullish, 4 bearish.
  • PBYI’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both NBTX and PBYI are a good buy in the short-term.

Price Growth

NBTX (@Biotechnology) experienced а +1.26% price change this week, while PBYI (@Biotechnology) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

NBTX is expected to report earnings on Sep 04, 2025.

PBYI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBTX($221M) has a higher market cap than PBYI($165M). NBTX YTD gains are higher at: 57.707 vs. PBYI (9.180).
NBTXPBYINBTX / PBYI
Capitalization221M165M134%
EBITDAN/A54.7M-
Gain YTD57.7079.180629%
P/E RatioN/A4.27-
RevenueN/A233M-
Total CashN/A93.2M-
Total DebtN/A61.7M-
FUNDAMENTALS RATINGS
PBYI: Fundamental Ratings
PBYI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBTXPBYI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASBFF27.88N/A
N/A
Associated British Foods plc
HRSEF105.81N/A
N/A
Hirose Electric
SOUTF0.04N/A
N/A
Southern Energy Corp.
CSGQF1.38N/A
N/A
Costain Group Plc
PMMCF0.12-0.01
-5.38%
Pampa Metals Corporation

NBTX and

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
-4.31%
PBYI - NBTX
28%
Poorly correlated
+0.60%
GLMD - NBTX
26%
Poorly correlated
+1.12%
ONCO - NBTX
25%
Poorly correlated
+3.87%
NVO - NBTX
24%
Poorly correlated
+1.20%
GLPG - NBTX
24%
Poorly correlated
+0.97%
More

PBYI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with AURA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBYI
1D Price
Change %
PBYI100%
+0.60%
AURA - PBYI
37%
Loosely correlated
-0.16%
ACIU - PBYI
37%
Loosely correlated
-2.90%
COGT - PBYI
37%
Loosely correlated
-3.14%
RGNX - PBYI
36%
Loosely correlated
-4.11%
VYGR - PBYI
35%
Loosely correlated
-0.34%
More